Praxis Precision Medicines (PRAX) is a clinical-stage biopharmaceutical company that develops therapies for central nervous system disorders. Marcio Souza, President and CEO of Praxis Precision Medicines, discusses the company, as it updates progress on therapies for Essential Tremor and Parkinson’s Disease. He also gives an overview of the company. Tune in to find out more.
04 Jan 2022
The Watch List
20 Apr 2022
The Watch List
28 Apr 2022
The Watch List
22 Feb 2022
The Watch List
01 Mar 2022
The Watch List
13 May 2022
Morning Trade Live
18 Mar 2022